Evidence map›Paper›PMID 31116734›Full record

ArticlePLoS genetics2019

CBX2 is required to stabilize the testis pathway by repressing Wnt signaling.

S Alexandra Garcia-Moreno, Yi-Tzu Lin, Christopher R Futtner, Isabella M Salamone, Blanche Capel, Danielle M Maatouk

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 75 citations in OpenAlex.

  1. Strain-Dependent Functional Variation of a Sex Specific Sox9 Enhancer.Genes to cells : devoted to molecular & cellular mechanisms · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Overexpression ofZoological research · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. CDYL reinforces male gonadal sex determination through epigenetically repressingProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

S Alexandra Garcia-MorenoDepartment of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois, United States of America.ORCID 0000-0003-2137-6114
Yi-Tzu LinDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina, United States of America.ORCID 0000-0002-2470-2053
Christopher R FuttnerDepartment of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois, United States of America.ORCID 0000-0003-3004-9983
Isabella M SalamoneDepartment of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois, United States of America.ORCID 0000-0002-0016-3091
Blanche CapelDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina, United States of America.ORCID 0000-0002-6587-0969
Danielle M MaatoukDepartment of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois, United States of America.
Northwestern University · USDuke Medical Center · US

Funding

CELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1M
TRAINING IN METABOLISM, DIABETES AND ENDOCRINOLOGYT32DK007169 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Joseph Bass · 1988 to 2026
$6.6M
OPPOSING PATHWAYS IN MAMMALIAN SEX DETERMINATIONR01HD039963 · NICHD · DUKE UNIVERSITY · PI CAPEL, BLANCHE · 2001 to 2025
$4.7M
Opposing Pathways in Mammalian Sex DeterminationR37HD039963 · NICHD · DUKE UNIVERSITY · PI CAPEL, BLANCHE · 2011 to 2020
$3.5M
Dose-specific responsiveness of glucocorticoid receptor-driven transcription in skeletal muscleF31AR073655 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SALAMONE, ISABELLA MARIE · 2019 to 2021
$118k
NIAMS NIH HHS F31 AR073655NICHD NIH HHS R01 HD039963NICHD NIH HHS R37 HD039963NIDDK NIH HHS T32 DK007169NIGMS NIH HHS T32 GM008061
6 · The paper itself

Abstract

XX and XY fetal gonads are initially bipotential, poised between the ovary and testis fate. Multiple lines of evidence suggest that commitment to testis fate requires the repression of genes associated with ovary fate. It was previously shown that loss of CBX2, the subunit of the Polycomb Repressive Complex 1 (PRC1) that binds H3K27me3 and mediates silencing, leads to ovary development in XY mice and humans. While it had been proposed that CBX2 is an activator of the testis-determining gene Sry, we investigated the alternative possibility that CBX2 has a direct role as a repressor of the antagonistic ovary-promoting pathway. To investigate this possibility, we developed a quantitative genome-wide profile of the repressive histone mark H3K27me3 and its active counterpart H3K4me3 in isolated XY and XX gonadal supporting cells before and after sex determination. We show that testis and ovary sex-determining (SD) genes are bivalent before sex determination, providing insight into how the bipotential state of the gonad is established at the epigenetic level. After sex determination, many SD genes of the alternate pathway remain bivalent, possibly contributing to the ability of these cells to transdifferentiate even in adults. The finding that many genes in the Wnt signaling pathway were targeted for H3K27me3-mediated repression in Sertoli cells led us to test whether deletion of Wnt4 could rescue testis development in Cbx2 mutants. We show that Sry expression and testis development were rescued in XY Cbx2-/-;Wnt4-/- mice. Furthermore, we show that CBX2 directly binds the downstream Wnt signaler Lef1, an ovary-promoting gene that remains bivalent in Sertoli cells. Our results suggest that stabilization of the testis fate requires CBX2-mediated repression of bivalent ovary-determining genes, which would otherwise block testis development.

Indexed as

Epigenesis, GeneticSex Determination ProcessesAnimalsEmbryo, MammalianFemaleFibroblast Growth Factor 9Forkhead Box Protein L2Gene Expression ProfilingGene Expression Regulation, DevelopmentalHistonesHumansLymphoid Enhancer-Binding Factor 1MaleMiceOvaryPlatelet Endothelial Cell Adhesion Molecule-1Cbx2 protein, mouseFgf9 protein, mouseFibroblast Growth Factor 9Forkhead Box Protein L2Foxl2 protein, mouseHistonesLef1 protein, mouseLymphoid Enhancer-Binding Factor 1Pecam1 protein, mousePlatelet Endothelial Cell Adhesion Molecule-1Polycomb Repressive Complex 1Sox9 protein, mouseSOX9 Transcription FactorSOXB1 Transcription FactorsWnt4 ProteinWnt4 protein, mouse

Identifiers

PMID31116734
PMCPMC6548405
OpenAlexW2946479989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.